
Cardiovascular Discovery Group | University of Sydney/Royal North Shore Hospital | @mpg@mastodon.online
Sydney, New South Wales
Joined October 2021
- Tweets44
- Following95
- Followers69
- Likes18
Michael Patrick Gray retweeted
🚨 BRAVO A DIEGO LUNA QUE AYER DIO UN EMOTIVO DISCURSO A FAVOR DE NUESTROS MIGRANTES
Esto lo hizo en el show de @jimmykimmel en California en el cual será anfitrión en los próximos días. Criticó el Discurso de Odio de Trump, resaltó la importancia de los migrantes en EU y la necesidad de que obtengan seguridad jurídica.
Retiro mis anteriores críticas, reconozco y aplaudo la valentía de Diego Luna...
Michael Patrick Gray retweeted
We had a great @CAD_Frontiers meeting @ACCinTouch together with @US_FDA and other industry/society partners. Great discussions on use of CCT for clinical trial enrichment as well as a potential surrogate biomarker #YesCCT #ClinicalTrials #Prevention @gemtreee 👏
Michael Patrick Gray retweeted
Thanks @nejm for hosting this important discussion with Global CV Risk Consortium highlighting the urgent need to identify and address new modifiable factors driving our biggest killer with >40% of risk unexplained nejm.org/doi/10.1056/NEJMc23… @CAD_Frontiers @OzCvA @KathyBelov
Important, invited perspective into Indigenous Americans medical inequities and contributions of the medical literature—including @NEJM —to these. Great piece. nejm.org/doi/full/10.1056/NE…
28
Congrats to all! Exciting to see this important effort in publication.
#CAD patients with no standard modifiable cardiovascular risk factors (SMuRFs) have an increased risk of early mortality in comparison to those with #CVD Risk factors: bit.ly/3sR5h3Z
#JACC #cvCAD #ASCVD #Atherosclerosis #cvPrev #CardioTwitter @gemtreee
Michael Patrick Gray retweeted
Catching up with @CAD_Frontiers industry partner @GiordanoBotta @Allelica_PRS and our own @gray_m_p @grieveler in #Roma thanks to direct @Qantas Perth-Rome @DrEmmaLJohnston @KathyBelov @CSHeartResearch @ProfSNicholls
Great opportunity to highlight the work of the @gemtreee group, BioHEART study, and area of significant unmet needs in #coronary dx at #scct2023. Congrats on a successful mtg! @Sydney_Uni @KollingINST @CAD_Frontiers
3
80
Fantastic session on SMuRFless #CAD @APSC2023 w @steve_vern @Suzanne75292842 and @Nicholaswschew. @gemtreee
Let’s continue the conversation ahead of #ESCCongress in #Amsterdam. Register today (free!)/learn more: cadfrontiers.com.au/news/new…
As we approach the holidays, the Miracle this season is that Manischewitz Crypto Gelt has miraculously held its value and not crashed like its fellow #cryptocurrencies.
1
Increasing public interest in our trial deliberately testing implementation of #genomics and a #PolygenicRiskScore in the primary care setting for earlier #heartattack prevention. A fantastic collaboration, with @NHMRC support. @gemtreee
linkedin.com/posts/joanna-ha…
Exciting times ahead! sydney.edu.au/news-opinion/n…
This Post is from an account that no longer exists. Learn more
3
Great piece highlighting an important opportunity for improvement. This novel #clinicaltrial incorporates polygenic risk score-triaged #coronary calcium scan into otherwise standard #CVD checks for earlier #CAD identification/aggressive treatment @9NewsSyd
#EXCLUSIVE: A test is being trialled in the hope of catching silent cases of heart disease.
Healthy patients with no obvious risk factors - such as high cholesterol and blood pressure - make up around a quarter of those who suffer heart attacks. @gabyrogers #9News
Trial to treat silent heart disease
1
A one day complete flip between @escardio and @EuroRespSoc. Impressive, Barcelona!
2
Very pleased to tell the groups story in beta-3 modulation, leading to a new clinical trial in peripheral arterial disease. Congrats on the great work @gemtreee @kristenbubb #ESCCongress
2
8
“Calcium score is essential in CVD: Con” - Tough assignment from #ESCCongress, @MichaelJBlaha!
4
Exciting to see the mPAP>20 story develop through the years into @escardio / @EuroRespSoc guideline integration. #esc2022 #pulmonaryhypertension pubmed.ncbi.nlm.nih.gov/2687…
Worlds colliding at #esc2022 with the #PulmonaryHypertension guidelines release


















